Table 1 The list of CPIs and their biological functions in different cancer types

From: Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer

Forms of action

CircRNA

RBP

Cancer

Biological function

Expression

year

Ref.

a. CPIs modulating transcription

circACTN4

YBX1

Intrahepatic cholangiocarcinoma(ICC)

circACTN4 recruiting YBX1 to initiate FZD7 transcription to promote ICC progression

2021

110

circNCOR1

hnRNPL

Bladder cancer(BCa)

circNCOR1 recruits hnRNPL to lymphangiogenesis and LN metastasis of BCa in vivo

2022

53

circMRPS35

KAT7

Gastric cancer(GC)

circMRPS35 recruits KAT7 to suppress GC cells progression

2020

111

circ-HuR

CNBP

Gastric cancer

circ-HuR inhibits CNBP’s binding to HuR promoter, preventing the progression of tum

2019

112

circRHOT1

TIP60

Hepatocellular carcinoma

circRHOT1 recruits TIP60 to initiate NR2F6 expression, which promotes HCC growth and metastasis

2019

113

circ-CUX1

EWSR1

Neuroblastoma

circ-CUX1 interacts with EWSR1 to facilitate its interaction with MAZ, inducing tumor progression

2019

114

circCAPRIN1

STAT2

Colorectal cancer

circCAPRIN1 binds STAT2 to regulate lipid metabolism and facilitates CRC tumorigenesis

2023

115

circRNF10

DHX15

Breast cancer

circRNF10 interacts with DHX15 to sequester DHX15 from NF-κB p65,suppressing BC’s proliferation and migration

2023

28

circRPPH1

UPF1,ATF3

Glioblastoma multiforme(GBM)

UPF1/circRPPH1/ATF3 forms a feedback loop to strengthen tumorigenesis of glioma stem cells

2022

30

circFMN2

HuR

Prostatic cancer(PC)

circFMN2 binds to HuR to represses KLF2 expression, which induces cell proliferation, invasion, and migration

2023

116

has_circ_0062682

YBX1

Hepatocellular carcinoma

has_circ_0062682 binds to YBX1 to promote oncogenesis in HCC

2022

117

circRPMS1

Sam68

Gastric carcinoma

ebv-circRPMS1 recruits Sam68 to induce METTL3 expression, resulting in cancer progression

2022

118

circ-DONSON

NURF

Gastric cancer

circ-DONSON recruits the NURF complex to activate SOX4 transcription, and facilitates GC growth and invasion

2019

10

has_circ_0101119

EIF4A3

Cervical cancer

has_circ_0101119 recruits EIF4A3 to facilitate cell process, and suppress apoptosis in CC

2021

119

circPSD3

HDAC1

Hepatocellular carcinoma

circPSD3 interacts with HDAC1 to inhibit vascular invasion and metastasis in HCC

2023

31

circ0005276

FUS

Prostate cancer

circ0005276 interacts with FUS to promote cell proliferation, migration and EMT of PCa

2019

120

circ_SIRT1

EIF4A3

Chronic myeloid leukemia(CML)

circ_SIRT1 binds to EIF4A3 and regulates transcription of ATG12,leading to lmatinib resistance in CML

2024

29

circEHD2

YWHAH

Renal cell carcinoma

circEHD2 interacts with YWHAH to activate transcriptional factor SOX9,which accelerates the growth of RCC

2023

121

circIPO11

TOP1

Hepatocellular carcinoma

circIPO11 recruits TOP1 to promote the propagation of HCC

2021

27

b. CPIs affecting alternative splicing

circSMARCA5

SRSF1

Glioblastoma

circSMARCA5 interacts with SRSF1 to induce anti-angiogenic and suppress tumor progression

2019

34

circURI1

hnRNPM

Gastric cancer

circURI1 inreracts with hnRNPM to promote the process of cell migration and suppressing GC metastasis

2021

32

circRAPGEF5

RBFOX2

Endometrial cancer(EC)

circRAPGEF5 interacts with RBFOX2 to promote the formation of TFRC and confer ferroptosis resistance in EC cells, which facilitates rapid proliferation of EC cells

2022

35

circCPSF6

CPSF6

Esophageal cell carcinoma

circCPSF6 interacts with CPSF6 to promote malignant development of ESCC

2022

122

circRNA_100290

EIF4A3

Gastric cancer

circRNA_100290 binds to EIF4A3 to inhibit itself formation, leading to suppressed GC cell proliferation, migration, and invasion

2021

123

circPLCE1

SRSF2

Colorectal cancer

circPLCE1 binds to SRSF2 protein to repress PLCE1 pre-RNA splicing,which up-regulates CRC

2021

124

circPDIA4

DHX9,ERK1/2

Gastric cancer

cytoplasmic circPDIA4 binds to ERK1/2, while circPDIA4 interacts with DHX9 as a decoy in the nucleus, which promotes GC progression

2023

125

c. CPIs affecting translation

circMYBL2

cpSF6

AML

circMYBL2 recruits PTBP1 to enhance FLT3 kinase expression and promote FLT3-ITD AML progression

2019

126

has_circ_0068631

EIF4A3

Breast cancer

EIF4A3 binds to has_circ_0068631 and c-Myc mRNA to promote BC progression

2021

127

circDLC1

HuR

Hepatocellular carcinoma(HCC)

circDLC1 interacts with HuR to inhibit MMP1-mediated HCC progression

2021

128

circ0008399

WTAP

Bladder cancer

circ0008399 unites WTAP to formate the WTAP/METTL3/METTL14 complex to inhibit apoptosis of BCa cells and reduce cisplatin sensitivity in Bca

2021

129

circLPAR1

eIF3h

Colorectal cancer(CRC)

exosomal circLPAR1 binds with eIF3h to suppress tumor growth

2022

130

circARHGAP29

EIF4A3,IGF2BP2

Prostate cancer(PC)

circARHGAP29 binds with EIF4A3 and IGF2BP2 to facilitate docetaxel resistance and glycolysis in PC

2022

81

circMYH9

hnRNPA2B1

Colorectal cancer(CRC)

circMYH9 recruits hnRNPA2B1 and destabilizes the pre-mRNA of p53,inducing tumor growth

2021

131

circITGB6

IGF2BP2

Ovarian cancer(OC)

circITGB6 interacts with both IGF2BP2 and FGF9 mRNA, inducing cisplatin resistance in OC

2022

89

circ-TNPO3

IGF2BP2

Clear cell renal cell carcinoma(ccRCC)

circ-TNPO3 binds to IGF2BP2 and destabilizes SERPINH1 mRNA, suppressing proliferation and migration of ccRCC cells

2022

38

circPTPRA

IGF2BP1

Bladder cancer

circPTPRA interacts with IGF2BP1 to abolish the promotion of BC cells

2021

50

circTICRR

HuR

Cervical cancer(CC)

circTICRR interacts with HuR to stabilize GLUD1 mRNA and inhibits CC cells’ autophagy

2022

132

has_circ_0005358

PTBP1

Cervical cancer

has_circ_0005358 sequesters PTBP1 form stabilizing CDCP1 mRNA,suppressing cancer metastasis

2022

51

circDCUN1D4

HuR

Lung adenocarcinoma

circDCUN1D4 facilitates the interaction between HuR protein and TXNIP mRNA to suppress tumor metastasis and glycolysis

2021

52

circPBX3

IGF2BP2

Ovarian cancer

circPBX3 interacts with IGF2BP2 to promote cisplatin resistance of OC cells

2022

80

circIPO7

caprin-1

Gastric cancer

circIPO7 binds to caprin-1 to block the caprin-1-G3BP1 interaction, resulting in suppressing GC cell proliferation

2023

133

circUHRF2

IGF2BP1

Colorectal cancer

circUHRF2 promotes the interaction between IGF2BP1 and DDX27 mRNA, which induces CRC stemness and metastasis

2023

134

circXRCC5

IGF2BP2

Glioma

circXRCC5 binds to IGF2BP2 to maintain mRNA stability of CLC3,which ultimately accelerate glioma growth

2023

135

circITGB6

IGF2BP3

Colorectal cancer

circITGB6 interacts with IGF2BP3 and enhances the PDPN mRNA’s stability, which promotes the EMT process

2023

136

circPCNX

AUF1

Cervical cancer

circPCNX sequesters AUF1 from p21 mRNA to inhibit proliferation in HeLa cells

2021

54

circASPH

IGF2BP2

Colorectal cancer

circASPH interacts with IGF2BP2 to stabilize its protein level to accelerate CRC progression

2023

137

circREOS

HuR

Osteosarcoma(OS)

circREOS sequesters HuR from MYC mRNA to inhibit OS

2023

138

circABCC4

IGF2BP2

Prostate cancer

circABCC4 recruits IGF2BP2 to promote stemness and metastasis of prostate cancer

2023

139

circSETD3

FXR1

Non-small lung cancer

circSETD3 interacts with FXR1 and facilitates its binding to ECT2,which inhibits cellular apoptosis

2023

82

hsa_circ_0006232

FUS,EZH2

Laryngeal squamous cell carcinoma

FUS interacts with hsa_circ_0006232 and EZH2 and promotes the stabilization of EZH2, which promotes the biological functions of LSCC cells

2021

140

circRABL2B

YBX1

Lung cancer

circRABL2B interacts with YBX1 to suppress lung cancer progression

2023

141

hsa_circ_0036200(Cpkm)

IGF2BP2

Intrahepatic cholangiocarcinoma(ICC)

cPKM binds to IGF2BP2 to enhance ICC’s progression and resistance to paclitaxel, leading to vascular collapse

2023

77

circXPO1

IGF2BP1

Lung adenocarcinoma

circXPO1 interacts with IGF2BP1 to enhance the stability of CTNNB1 mRNA to promote LUAD progression

2020

142

circKIF4A

EIF4A3

Triple-negative breast cancer(TNBC)

circKIF4A binds to EIF4A3 to stabilize SDC1 mRNA, resulting in promoting TNBC progression

2023

143

circARHGAP5

AUF1

Cervival squamous cell carcinoma(CSCC)

circARHGAP5 sequesters AUF1 from BIM mRNA, which induces cisplatin resistance in CSCC

2023

144

hsa_circ_0074854

HuR

Hepatocellular carcinoma

hsa_circ_0074854 knockdown interacts with HuR to reduce its stability, leading to inhibiting HCC cells’ migration and invasion

2021

145

circ-TNPO3

IGF2BP3

Gastric cancer

circ-TNPO3 competes with IGF2BP3 to disrupt its ability to stabilize MYC mRNA, resulting in the inhibition of GC cells

2021

146

circ-MMP9

AUF1

Oral squamous cell carcinoma

circ-MMP9 binds to AUF1 to increase MMP9 mRNA’s stability, which facilitates OSCC metastasis

2019

147

circ-0075804

HNRNPK

Retinoblastoma(RB)

circ-0075804 interacts with HNRNPK to increase E2F3 mRNA stability, which promotes RB cells’ proliferation

2020

148

circRBM33

FMR1

Prostate cancer

m6A-modified circRBM33 interacts with FMR1 and sustain the mRNA stability of PDHA1,which promotes PCa progression

2023

149

circNSUN2

IGF2BP2

Colorectal carcinoma

circNSUN2 forms a circNSUN2/IGF2BP2/HMGA2 ternary complex to promote CRC metastasis

2019

44

d. CPIs affecting subcellular localization

circIPO7

YBX1

Nasopharyngeal carcinoma(NPC)

circIPO7 binds to YBX1 protein and facilitates its phosphorylation to promote NPC metastasis and cisplatin chemoresistance

2022

56

circSPARC

FUS

Colorectal cancer

circSPARC recruits FUS and facilitates STAT3’s nuclear translocation, which promotes CRC cell migration and proliferation

2021

57

has_circ_0005050

ILF3

Arsenic carcinoma

has_circ_0005050 interacts with ILF3 to facilitate its translocation to cytoplasm, leading to cell apoptosis and proliferation

2022

150

circTBC1D14

FUS

Triple-negative breast cancer

circTBC1D14 can promote the interaction between FUS and LAMP1,promoting tumor progression in TNBC

2023

151

circHIF1A

NFIB,FUS

Triple-negative breast cancer

circHIF1A/NFIB/FUS forms a positive feedback loop to promote TNBC growth and metastasis

2021

39

 

hsa_circ_0067842

HuR

Breast cancer

hsa_circ_0067842 interacts with HuR to promote the migration and invasion of BC cells

2023

55

circ-ABCC1

β-catenin

Colorectal cancer

circ-ABCC1 interacts with β-catenin to facilitate CRC progression and metastasis

2020

152

circ_GRHPR

PCBP2

Non-small cell lung cancer(NSCLC)

circ_GRHPR interacts with PCBP2 to promote NSCLC proliferation and invasion

2021

153

circIMMP2L

CtBP1

Esophageal squamous cell carcinoma

circIMMP2L interacts with CtBP1 and facilitates its nuclear retention in the nucleus, which promotes ESCC’s progression

2021

154

circEML4

ALKBH5

Non-small cell lung cancers

circEML4 interacts with ALKBH5 to reduce its distribution in the nucleus, resulting in promoting the NSCLC progression

2023

155

circTET2

HNRNPC

Chronic lymphocytic leukemia(CLL)

m6A-modified circTET2 interacts with HNRNPC and restricts its transportation from the nucleus to the cytoplasm, which promotes the proliferation of CLL

2023

156

circAGO2

HuR

-

circAGO2 facilitates HuR’s translocation from the nucleus to cytoplasm, leading to the promotion of tumorigenesis

2019

157

e. CPIs affecting PTM

circRNA-CREIT

DHX9

Triple-negative breast cancer(TNBC)

circRNA-CREIT interacts with DHX9 to induce a lower expression and worse prognosis of patients

2022

158

phosphorylation

circEIF3I

SMAD3,AP2A1

Pancreatic ductal adenocarcinoma(PDAC)

circEIF3I binds both SMAD3 and AP2A1 and promote PDAC progression

2023

106

circNFIB

MEK1

Intrahepatic cholangiocarcinoma

circNFIB binds to MEK1 to inhibit ICC growth and metastasis

2022

59

circLIFR

MSH2

Bladder cancer

circLIFR interacts with MSH2 to mediate cisplatin(CDDP) sensitivity in BCa cells

2021

92

circCYP24A1

PKM2

Esophageal cell carcinoma(ESCC)

circCYP24A1 interacts with PKM2 to increase CCL5 secretion, which promotes the proliferation ability and tumor growth

2022

159

circGNG7

HSP27

Head and neck squamous cell carcinoma(HNSCC)

circGNG7 binds to HSP27 to hinder its phosphorylation, which inhibits tumor cell proliferation, colony formation

2021

160

circPTK2

vimentin

Colorectal cancer

circPTK2 binds to vimentin protein to promote EMT of CRC cells

2020

161

circGSK3β

GSK3β

Esophageal squamous cell carcinoma(ESCC)

circGSK3β sequesters GSK3β from β-catenin to promote ESCC cell metastasis

2019

162

circ-GLI1

p70S6K2

Melanoma

circ-GLI1 interacts with p70S6K2 to promote metastasis in melanoma

2020

163

ubiqutination

circPDK1

UBE20,B1N1

Pancreatic cancer(PC)

circPDK1 enhances the interaction between UBE20 and B1N1 to induce PC proliferation, migration,and glycolysis

2022

164

circPOLR2A

UBE3C,PEBP1

Clear cell renal cell carcinoma(cRCC)

circPOLR2A interacts with both UBE3C and PEBP1 proteins to accelerate the proliferation, migration and angiogenesis of cRCC cells

2022

165

circNDUFB2

TRIM25,IGF2BPs

Non-small cell lung cancer

circNDUFB2 enhances the interaction between TRIM25 and IGF2BPs to promote NSCLC progression and metastasis

2021

45

circARHGAP10

TRIM25,MAT2A

Bladder cancer

circARHGAP10 enhances the interaction between TRIM25 and MAT2A to induce cisplatin resistance in BCa cells

2023

95

circPFKFB4

CRL4DDB2 E3 ubiquitin ligase

Breast cancer

circPFKFB4 interacts with CRL4DDB2 E3 ubiquitin ligase to promote the proliferation of BC cells

2022

166

CircCDR1as

SRSF1

Lung cancer

circCDR1as binds to SRSF1 to mediate PM2.5-induced lung cancer progression.

2023

167

circSCL38A1

ILF3

Bladder cancer

circSCL38A1 could interact with and stabilize ILF3 to promote BCa cell invasion and lung metastasis

2023

168

circMTCL1

C1QBP

Laryngeal squamous cell carcinoma(LSCC)

circMTCL1 recruits C1QBP protein to accelerate its translation and promote tumor cell proliferation invasion and migration

2022

169

circCDYL2

GRB7,FAK

Breast cancer

circCDYL2 binds both GRB7 and FAK protein to promote drug resistance of HER2 BC cells

2022

101

circRNA-SORE

YBX1

Hepatocellular carcinoma

circRNA-SORE binds to YBX1 and blocks its degradation, inducing sorafenib resistance in HCC

2020

83

circNEIL3

YBX1

Colorectal carcinoma

circNEIL3 interacts with YBX1 and promotes its degradation to inhibit tumor metastasis

2023

170

circWSB1

USP10

Breast cancer

hypoxia-induced circWSB1 competitively binds to USP10,resulting in degradation of p53 and BC progression

2022

171

circSKA3

SLUG

Colorectal cancer

circSKA3 binds to SLUG to promote EMT to accelerate CRC metastasis

2023

172

 

circRNA-SFMBT2

RNF181,ERα

Breast cancer

circRNA-SFMBT2 recruits RNF181 to ERα to enhance ERα stability, leading to tumor progression

2023

173

circCLNS1A

LARP1

Hepatoblastoma(HB)

O-GlcNAcylation of LARP1 enhances its binding to circCLNS1A and facilitates HB progression

2023

174

circNFATC3

IGF2BP3

Gastric cancer

circNFATC3 binds to IGF2BP3 and restricts its ubiquitination to promote the proliferation of GC

2023

65

circSKA3

β-catenin

Colorectal cancer

circSKA3 binds to β-catenin and protects them from ubiquitinated degradation, which promotes CRC progression

2023

175

neddylation

circAFF2

CAND1,Cullin1

Colorectal cancer

circAFF2 binds CAND1, enhancing its interaction with Cullin1 and inhibiting neddylation, impacting CRC radiosensitivity

2023

68

SUMOylation

circTLCD4-RWDD3

hnRNPA2B1

Non-small cell lung cancer

circTLCD4-RWDD3 interacts and induces hnRNPA2B1 SUMOylation to promote lymphatic metastasis of NSCLC

2023

71

glycosylation

circSPIRE1

ELAVL1,mRNA

Renal cell carcinoma(RCC)

circSPIRE1 binds both ELAVL1 and mRNA to suppress metastasis of RCC

2023

73

acetylation

circPTPN22

STAT3

Pancreatic cancer

circPTPN22 promotes STAT3 acetylation via inhibiting the interaction between STAT3 and SIRT1,which attenuates PC immune microenvironment

2023

176

lactylation

circXRN2

LAST1

Bladder cancer

circXRN2 interacts with SPOP to inhibit the proliferation and migration of tumor cells

2023

177

f. The form that has not been elaborated in detail

circRNA-101093

FABP3

Lung adenocarcinoma(LUAD)

exosomal cir93 interacts with and increases FABP3, reducing llipid peroxidation and desensitized LUAD cells to ferroptosis

2022

178

circRNA_102231

IRTKS

Gastric cancer

circRNA_102231 binds to and increases IRTKS stability, leading to GC progression

2021

179

circEXOC6B

RRAGB

Colorectal cancer

circEXOC6B binds to RRAGB and suppresses the Mtorc1 pathway and HIF1A level, which inhibits growth and increases apoptosis of CRC cells

2022

180

circCDYL2

Ezrin

Colorectal cancer

circCDYL2 interacts with Ezrin and increases its protein levels, which induces CRC cell migration in vitro

2021

181

Circ SMARCA5

SND1

Cervical cancer

circ SMARCA5 interacts with SND1 to inhibit SND1’s binding to YWHAB, and suppresses CC metastasis

2021

182

circPFKP

IMPDH2,hnRNPF

Prostate cancer

circPFKP interacts with IMPDH2 to promote the biogenesis of guanine nucleotides and facilitate PCa cells’proliferation

2022

25

circHIPK3

VCP

Bladder cancer

circHIPK3 interacts with VCP and blocks VCP binding to the Beclin1 complex, which suppresses autophagy in BC cells

2023

183